Immunotherapy News and Research

Latest Immunotherapy News and Research

First-in-human trial shows safety and efficacy of CAR T cell therapy for advanced prostate cancer

First-in-human trial shows safety and efficacy of CAR T cell therapy for advanced prostate cancer

UC Davis pioneers advanced PET imaging to monitor lung cancer treatment

UC Davis pioneers advanced PET imaging to monitor lung cancer treatment

Targeting epigenetic enzymes in dendritic cells to improve cancer immunotherapy

Targeting epigenetic enzymes in dendritic cells to improve cancer immunotherapy

New hope for BCG-unresponsive bladder cancer patients with innovative combination therapy

New hope for BCG-unresponsive bladder cancer patients with innovative combination therapy

‘Artificial lymph node’ shows potential to treat cancer

‘Artificial lymph node’ shows potential to treat cancer

Ultrasound technology breaks blood-brain barrier for glioblastoma treatment

Ultrasound technology breaks blood-brain barrier for glioblastoma treatment

Researchers identify a potential metabolic target for cancer immunotherapy

Researchers identify a potential metabolic target for cancer immunotherapy

Short course of immunotherapy prior to surgery effective in treating a subset of colon cancer patients

Short course of immunotherapy prior to surgery effective in treating a subset of colon cancer patients

UC San Diego Health launches personalized immunotherapy for metastatic melanoma

UC San Diego Health launches personalized immunotherapy for metastatic melanoma

Understanding the role of tumor-associated fibrosis in immunotherapy resistance

Understanding the role of tumor-associated fibrosis in immunotherapy resistance

Wistar scientists develop Persistent Multivalent T Cell Engager for advanced kidney cancer

Wistar scientists develop Persistent Multivalent T Cell Engager for advanced kidney cancer

Novel combination treatment outperforms standard therapy in patients with EGFR NSCLC

Novel combination treatment outperforms standard therapy in patients with EGFR NSCLC

SU2C-SARC032 trial: Immunotherapy reduces relapse risk in soft tissue sarcoma by 43%

SU2C-SARC032 trial: Immunotherapy reduces relapse risk in soft tissue sarcoma by 43%

Experimental treatment for metastatic pancreatic cancer shows promise in phase 2 clinical trial

Experimental treatment for metastatic pancreatic cancer shows promise in phase 2 clinical trial

New treatment approach could offer longer lasting protection to people with breast cancer

New treatment approach could offer longer lasting protection to people with breast cancer

Stress and pain linked to worse outcomes in HER2-positive breast cancer patients

Stress and pain linked to worse outcomes in HER2-positive breast cancer patients

New method enhances the efficacy of bispecific antibody therapies in treating solid tumors

New method enhances the efficacy of bispecific antibody therapies in treating solid tumors

Study examines the cost-effectiveness of a targeted immunotherapy for lung cancer

Study examines the cost-effectiveness of a targeted immunotherapy for lung cancer

Research reveals how Regnase-1 deficiency enhances NK cell tumor killing

Research reveals how Regnase-1 deficiency enhances NK cell tumor killing

Genomic evidence of prenatal origins in childhood acute myeloid leukemia

Genomic evidence of prenatal origins in childhood acute myeloid leukemia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.